levothyroxine sodium 0.175 MG/ML Oral Solution [Tirosint]

RxCUI
2056506
RxNorm name
levothyroxine sodium 0.175 MG/ML Oral Solution [Tirosint]
Display name
TIROSINT (Oral Liquid)
Full name
levothyroxine sodium 0.175 MG/ML Oral Solution [Tirosint]
Term type
SBD
Status
Active
Strength
0.175 mg/ml
Dose form
Sol
Route
Oral Liquid
Updated
2026-11-08 10:17:19

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102018
Active start
102018
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
levothyroxine sodium0.175 MG / 1 MLlevothyroxinelevothyroxine sodium

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
levothyroxine10582

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRTirosint SOL 0.175 MG per 1 ML Oral Solution1NAMES
RxNorm Namelevothyroxine sodium 0.175 MG/ML Oral Solution [Tirosint]1NAMES
RxNorm SynonymTirosint SOL 0.175 MG per 1 ML Oral Solution1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID5d378add-f13d-40f2-99dc-0f2340ab44b71CODES
RxCUI20565061CODES
MMSL_CODEBD314341CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
71858-0155-271858-0155Tirosint Levothyroxine SodiumIBSA Pharma Inc.NDA206977
71858-0155-571858-0155Tirosint Levothyroxine SodiumIBSA Pharma Inc.NDA206977

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA20697771858-0155Tirosint Levothyroxine SodiumNDAIBSA Pharma Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.

NDC11, Source, Active table
NDC11SourceActive
71858015501rxnav_ndcsyes
71858015502rxnav_ndcsyes
71858015504rxnav_ndcsyes
71858015505rxnav_ndcsyes
71858015506rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Tirosint SOLLEVOTHYROXINE SODIUMIBSA Pharma Inc.5d378add-f13d-40f2-99dc-0f2340ab44b72026-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 71858-0155-5
ndc (package): 71858-0155-2
ndc (product): 71858-0155
ndc11 (package): 71858015504
ndc11 (package): 71858015502
ndc11 (package): 71858015501
ndc11 (package): 71858015506
ndc11 (package): 71858015505
rxcui: 2056506

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5d378add-f13d-40f2-99dc-0f2340ab44b7TIROSINT - SOL 175 MCG in 1 mL Oral Solution [PSN] · levothyroxine sodium 0.175 MG/ML Oral Solution [Tirosint] [SBD] · Tirosint SOL 0.175 MG per 1 ML Oral Solution [SY]318These highlights do not include all the information needed to use TIROSINT ® -SOL safely and effectively. See full prescribing information for TIROSINT ® -SOL. Initial U.S. Approval: 200020260327

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
5d378add-f13d-40f2-99dc-0f2340ab44b7These highlights do not include all the information needed to use TIROSINT ® -SOL safely and effectively. See full prescribing information for TIROSINT ® -SOL. Initial U.S. Approval: 2000IBSA Pharma Inc.20260327

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCH03AAThyroid hormonesATC1-4levothyroxine sodium
FDASPLD013974ThyroxineCHEMhas_chemical_structurelevothyroxine
FDASPLN0000175945l-ThyroxineEPChas_epclevothyroxine
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine sodium
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine sodium
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine sodium
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine sodium
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine sodium
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine sodium
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine sodium
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine sodium
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine sodium
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine sodium

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.175 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA206977
NAMESPrescribable SynonymTIROSINT - SOL 175 MCG in 1 mL Oral Solution
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon